^
Association details:
Evidence:
Evidence Level:
Sensitive: D – Preclinical
Source:
Title:

1075 / 2 - Therapeutic targeting of CBFA2T3-GLIS2 infant AML with ELU001 - folate receptor alpha-directed C’Dot-drug-conjugate

Published date:
03/09/2022
Excerpt:
...we demonstrated that ELU001 is highly effective at eliminating FOLR1 positive AML cells in vitro and in vivo…